NCT02515227: A trial that was reported late by Craig L Slingluff, Jr
This trial has reported, although it was 805 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02515227 |
|---|---|
| Title | A Trial to Evaluate the Safety, Immunogenicity, and Clinical Activity of a Helper Peptide Vaccine Plus PD-1 Blockade |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 6, 2016 |
| Completion date | March 14, 2020 |
| Required reporting date | March 14, 2021, midnight |
| Actual reporting date | May 28, 2023 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | 805 |